Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 6 December 1985:
Vol. 230. no. 4730, pp. 1157 - 1160
DOI: 10.1126/science.3865369

Articles

Science, Vol 230, Issue 4730, 1157-1160
Copyright © 1985 by American Association for the Advancement of Science


articles

A transgenic mouse model of the chronic hepatitis B surface antigen carrier state

FV Chisari, CA Pinkert, DR Milich, P Filippi, A McLachlan, RD Palmiter, and RL Brinster

In an attempt to establish a model of the healthy carrier state in hepatitis B virus (HBV) infections, transgenic mice expressing HBV genes were produced. Fertilized one-cell eggs were microinjected with subgenomic fragments of HBV DNA containing the coding regions for the HBV surface antigen (HBsAg) and pre-S and X antigens. Either the normal (HBV) or metallothionein promoters were used to obtain expression of the HBV genes. There was no evidence of viral replication or tissue pathology. The integrated HBV DNA sequences were inherited in a normal Mendelian fashion. Three of 16 transgenic mice expressed HBV-encoded gene products to which they were immunologically tolerant. Expression was not tissue specific and may be influenced by the genomic integration site and cellular factors. Both HBsAg and pre-S antigen were detectable within the cytoplasm of hepatocytes and renal tubular epithelial cells. High serum concentrations of HBsAg were detectable and the secreted product appeared authentic as judged by mean density, morphology, mean particle diameter, polypeptide composition, and antigenicity. The absence of tissue pathology in these immunologically tolerant animals supports the hypothesis that cellular injury under these conditions is not a direct consequence of expression of the pre-S or HBs regions of the HBV genome.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Elimination of Immunodominant Epitopes from Multispecific DNA-Based Vaccines Allows Induction of CD8 T Cells That Have a Striking Antiviral Potential.
P. Riedl, A. Wieland, K. Lamberth, S. Buus, F. Lemonnier, K. Reifenberg, J. Reimann, and R. Schirmbeck (2009)
J. Immunol. 183, 370-380
   Abstract »    Full Text »    PDF »
Separate Origins of Hepatitis B Virus Surface Antigen-Negative Foci and Hepatocellular Carcinomas in Transgenic HBsAg (alb/psx) Mice.
D. R. Crawford, S. Ostrowski, D. Vakharia, Z. Ilic, and S. Sell (2006)
Am. J. Pathol. 169, 223-232
   Abstract »    Full Text »    PDF »
Distinct, Cross-Reactive Epitope Specificities of CD8 T Cell Responses Are Induced by Natural Hepatitis B Surface Antigen Variants of Different Hepatitis B Virus Genotypes.
P. Riedl, A. Bertoletti, R. Lopes, F. Lemonnier, J. Reimann, and R. Schirmbeck (2006)
J. Immunol. 176, 4003-4011
   Abstract »    Full Text »    PDF »
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses.
S. F. Wieland and F. V. Chisari (2005)
J. Virol. 79, 9369-9380
   Full Text »    PDF »
High Prevalence of Hepatitis B Virus Pre-S Mutant in Countries Where It Is Endemic and Its Relationship with Genotype and Chronicity.
T. T.-T. Huy, H. Ushijima, K. M. Win, P. Luengrojanakul, P. K. Shrestha, Z.-H. Zhong, A. V. Smirnov, T. C. Taltavull, T. Sata, and K. Abe (2003)
J. Clin. Microbiol. 41, 5449-5455
   Abstract »    Full Text »    PDF »
Molecular Characterization of the Human La Protein{middle dot}Hepatitis B Virus RNA.B Interaction in Vitro.
S. Horke, K. Reumann, A. Rang, and T. Heise (2002)
J. Biol. Chem. 277, 34949-34958
   Abstract »    Full Text »    PDF »
Characterization of Nuclear RNases That Cleave Hepatitis B Virus RNA near the La Protein Binding Site.
T. Heise, L. G. Guidotti, and F. V. Chisari (2001)
J. Virol. 75, 6874-6883
   Abstract »    Full Text »
Viruses, Immunity, and Cancer: Lessons from Hepatitis B.
F. V. Chisari (2000)
Am. J. Pathol. 156, 1117-1132
   Full Text »    PDF »
La Autoantigen Specifically Recognizes a Predicted Stem-Loop in Hepatitis B Virus RNA.
T. Heise, L. G. Guidotti, and F. V. Chisari (1999)
J. Virol. 73, 5767-5776
   Abstract »    Full Text »
Hepatitis B Virus RNA-Binding Proteins Associated with Cytokine-Induced Clearance of Viral RNA from the Liver of Transgenic Mice.
T. Heise, L. G. Guidotti, V. J. Cavanaugh, and F. V. Chisari (1999)
J. Virol. 73, 474-481
   Abstract »    Full Text »    PDF »
Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice.
Y. Shimizu, L. G. Guidotti, P. Fowler, and F. V. Chisari (1998)
J. Immunol. 161, 4520-4529
   Abstract »    Full Text »    PDF »
Immune Pathogenesis of Hepatocellular Carcinoma.
Y. Nakamoto, L. G. Guidotti, C. V. Kuhlen, P. Fowler, and F. V. Chisari (1998)
J. Exp. Med. 188, 341-350
   Abstract »    Full Text »    PDF »
Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.
T Moriyama, S Guilhot, K Klopchin, B Moss, C. Pinkert, R. Palmiter, R. Brinster, O Kanagawa, and F. Chisari (1990)
Science 248, 361-364
   Abstract »    PDF »
Transgenic animals.
R Jaenisch (1988)
Science 240, 1468-1474
   Abstract »    PDF »
Transcriptional Regulation of the TFIIH Transcription Repair Components XPB and XPD by the Hepatitis B Virus x Protein in Liver Cells and Transgenic Liver Tissue.
I. Jaitovich-Groisman, N. Benlimame, B. L. Slagle, M. H. Perez, L. Alpert, D. J. Song, N. Fotouhi-Ardakani, J. Galipeau, and M. A. Alaoui-Jamali (2001)
J. Biol. Chem. 276, 14124-14132
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)